The Medicines and Healthcare products Regulatory Agency (MHRA) led on a joint consultation on proposed amendments to the MHRA’s statutory fees with the Department of Health in Northern Ireland, in accordance with Section 45(1) of the Medicines and Medical Devices Act 2021.

The consultation ran between 31 August and 23 November 2022 to seek views on proposals to update the statutory fees charged for the MHRA’s regulatory services. The fees are set on a cost recovery basis, in accordance with Managing Public Money guidelines, however they have not been updated for several years and are not fully recovering costs.

Read the response to the consultation on proposals to increase statutory fees to recover costs, here: https://www.gov.uk/government/consultations/consultation-on-proposals-for-changes-to-the-medicines-and-healthcare-products-regulatory-agencys-statutory-fees